Search alternatives:
ns decrease » _ decrease (Expand Search), use decreased (Expand Search), ash decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ns decrease » _ decrease (Expand Search), use decreased (Expand Search), ash decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11941
Table_3_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf
Published 2024“…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
-
11942
Table_1_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf
Published 2024“…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
-
11943
Image_3_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf
Published 2024“…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
-
11944
Image_1_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf
Published 2024“…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
-
11945
Image_4_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf
Published 2024“…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
-
11946
Table_6_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf
Published 2024“…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
-
11947
Table_2_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf
Published 2024“…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
-
11948
Table_4_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf
Published 2024“…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
-
11949
-
11950
Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways...
Published 2016“…Time-dependent increases in the expression of JAK2 phosphorylated at Tyr1007/1008 (P-JAK2) in activated N2a Swe cells. <b>C</b> and <b>D</b>. Concentration-dependent decreases in P-JAK2 expression by taxifolin (10 ~ 50 μM), cilostazol (10 ~ 50 μM), and 20 μM AG490 (a JAK2 inhibitor) determined after culture in medium containing 1% FBS for 3 hr. …”
-
11951
-
11952
Data_Sheet_5_Construction and Analysis of a ceRNA Network in Cardiac Fibroblast During Fibrosis Based on in vivo and in vitro Data.PDF
Published 2021“…Finally, two mRNA [ADAM metallopeptidase domain 19, (ADAM19) and transforming growth factor beta induced, (TGFBI)], three microRNA (miR-9-5p, miR-124-3p, and miR-153-3p) and two lncRNA (LINC00511 and SNHG15) constituted our ceRNA network. siRNA against LINC00511 increased miR-124-3p and miR-9-5p expression, and decreased ADAM19 and TGFBI expression, whereas siRNA against SNHG15 increased miR-153-3p and decreased ADAM19 expression. …”
-
11953
Image_2_CREB3L2 Modulates Nerve Growth Factor-Induced Cell Differentiation.JPEG
Published 2021“…Also, Rab5 immunofluorescence levels decrease in CREB3L2-depleted cells. …”
-
11954
Image_3_CREB3L2 Modulates Nerve Growth Factor-Induced Cell Differentiation.JPEG
Published 2021“…Also, Rab5 immunofluorescence levels decrease in CREB3L2-depleted cells. …”
-
11955
Image_1_CREB3L2 Modulates Nerve Growth Factor-Induced Cell Differentiation.JPEG
Published 2021“…Also, Rab5 immunofluorescence levels decrease in CREB3L2-depleted cells. …”
-
11956
Data_Sheet_1_Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127.PDF
Published 2021“…<p>Glycogen synthase kinase 3 (GSK3) is a proline-directed serine-threonine kinase that is associated with several neurological disorders, including Alzheimer’s disease and fragile X syndrome (FXS). We tested the efficacy of a novel GSK3 inhibitor AFC03127, which was developed by Angelini Pharma, in comparison to the metabotropic glutamate receptor 5 inhibitor 2-Methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP) and the GSK3 inhibitor SB216763 in in vivo and in vitro assays in Fmr1<sup>KO</sup> mice, a mouse model useful for the study of FXS. …”
-
11957
-
11958
-
11959
-
11960
DataSheet_1_Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.docx
Published 2022“…However, the mechanisms through which these anti-ACE2 antibodies are induced during SARS-CoV-2 infection are unclear. In this study, we confirmed the increase in antibodies against ACE2 in patients with COVID-19 and found a positive correlation between the amounts of antibodies against ACE2 and S1-RBD. …”